Dr. Guillamot is currently Scientific Director at Seqens. He served as R&D project leader from 1984 to 1993 under Merrell Dow organization then as an R&D manager from 1993 to 1998 under Schwarz Pharma, before getting a position of R&D Director (1999 to 2017) within PCAS (now a division of Seqens).